CSP-504 - Risperidone Treatment for Military Service Related Chronic Post-Traumatic Stress Disorder.
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2016
At a glance
- Drugs Risperidone (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Acronyms CSP-504
- 02 Feb 2016 Results of secondary analyses (n = 267) published in the Journal of Clinical Psychiatry
- 03 Aug 2011 Results published in the JAMA: the Journal of the American Medical Association.
- 03 Aug 2011 Primary endpoint 'Clinician-Administered-Post-Traumatic-Stress-Disorder-Scale' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History